The preoperative diagnosis for IHL-ICC is mainly obtained from a combination of imaging, serum carcinoembryonic antigen (CEA), and cancer antigen 19-9 (CA 19-9). This evidence concerns the gene CEACAM5 and intrahepatic cholangiocarcinoma.